This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Stroke, Volume 55, Issue Suppl_1 , Page AWP288-AWP288, February 1, 2024. Background:Cerebrovascular diseases (CVD) represent a Global Health concern, being the first cause of disability worldwide and second cause of mortality (first in Brazil). Mortality percentages were: SAH=20.2%, ICH=25.3%, Ischemic Stroke=15.3%. were Female.
Stroke, Volume 56, Issue Suppl_1 , Page A78-A78, February 1, 2025. Introduction:Intracranial aneurysm (IA), a cerebrovasculardisease affecting 3-5% of US population, leads to subarachnoid hemorrage.
Stroke, Volume 56, Issue Suppl_1 , Page ATMP88-ATMP88, February 1, 2025. Introduction:Pediatric and young adult cerebrovasculardisease is more commonly associated with genetic conditions compared to in adults. Individuals with perinatal or isolated arterial ischemic stroke were not included.
Stroke, Volume 55, Issue Suppl_1 , Page ATP280-ATP280, February 1, 2024. As access and coverage of genetic testing has increased, it is being used more commonly in adults with strokes. Indications for testing included evaluation of carotid and vertebral dissections, recurrent stroke, cryptogenic stroke, and leukoencephalopathy.
Stroke, Volume 55, Issue Suppl_1 , Page ATP284-ATP284, February 1, 2024. Objectives:Moyamoya Disease (MMD) is a progressive occlusive cerebrovasculardisease with unknown etiology and pathogenesis. Peripheral blood mononuclear cells (PBMCs) were isolated and cryopreserved.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionInterventional Neurology (IN) is a rapidly expanding field, with new devices and techniques broadening the range of cerebrovasculardiseases that can be treated (1). All participants provided consent.
Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 1,2 ASCVD causes or contributes to conditions that include coronary artery disease (CAD), cerebrovasculardisease, and peripheral vascular disease (inclusive of aortic aneurysm).3
During the American Stroke Association’s International Stroke Conference 2024, ISC24, eleven scientists leading the way in stroke research will be recognized for their exceptional professional achievements. Sacco Outstanding Stroke Research Mentor Award, which honors Ralph L. 7-9 in Phoenix, AZ. 7-9 in Phoenix, AZ.
Look for Vascular Etiology -- think of these while doing H and P: --Bleeding: ruptured AAA, GI bleed, ruptured ectopic pregnancy, other spontaneous bleed such as mesenteric aneurysms. Negative predictors included dementia, pacemaker, coronary revascularization, and cerebrovasculardisease. to 1.45) for fatal or nonfatal stroke.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
40 
Let's personalize your content